Merchant R N, Doctor V M, Thaku S S, Sinha M, Jhaveri C L, Kessel E, Mumford S D
Adv Contracept. 1986 Mar;2(1):79-90. doi: 10.1007/BF01849300.
This study lends support to others indicating the apparent safety and effectiveness of multiple transcervical insertions of quinacrine hydrochloride as pellets in 240 mg dosage to achieve permanent sterilization. In order to study the effects of the number of quinacrine pellet insertions and the site of placement of the pellets in the uterus of prehysterectomy volunteers, a scoring system of histological changes in the Fallopian tube was designed. Quinacrine pellets were deposited at the fundus using a straight inserter in 16 women, and at the cornua using a curved inserter in 17 women. Each group had at least five women receiving one, two or three insertions at one-week intervals. Results indicate that neither the number of insertions nor the place of deposition of the pellets affects the degree of tubal inflammation and fibrosis.
本研究为其他研究提供了支持,这些研究表明,以240毫克剂量的盐酸阿的平制成药丸经宫颈多次插入以实现永久绝育具有明显的安全性和有效性。为了研究盐酸阿的平药丸插入次数以及药丸在子宫切除术前志愿者子宫内放置位置的影响,设计了一种输卵管组织学变化评分系统。使用直型插入器将盐酸阿的平药丸放置在16名女性的子宫底部,使用弯型插入器将药丸放置在17名女性的子宫角部。每组至少有五名女性,她们每隔一周接受一、二或三次插入。结果表明,插入次数和药丸放置位置均不影响输卵管炎症和纤维化程度。